Insulin Aspart (NovoLog)

04/01/2003 - "Insulin aspart has been shown to improve post-prandial and overall glycaemic control in people with Type 1 diabetes. "
01/01/2004 - "Limited studies show insulin aspart to be effective in children, adolescents and young adults with type 1 diabetes. "
02/01/2006 - "The aim of the present 3-year study was to evaluate the long-term safety and efficacy of insulin aspart in people with type 1 diabetes. "
01/01/2021 - "Safety and efficacy of GP40071 compared with originator insulin aspart (NovoRapid® Penfill®) in Type 1 diabetes mellitus."
01/01/2018 - "To compare the safety and efficacy of fast-acting insulin aspart (faster aspart) with conventional insulin aspart (IAsp) in adults with type 1 diabetes (T1D). "

11/01/2023 - "Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial."
02/01/2017 - "Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal-Bolus): Exploratory Randomized Trial in Type 2 Diabetes."
01/01/2017 - "Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial."
05/01/2005 - "Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial."
11/01/2023 - "Treatment with faster aspart resulted in similar fetal growth and HbA1c, relative to insulin aspart, in women with type 1 or type 2 diabetes. "

10/01/2022 - "Conclusions: In adults with T1D, HbA1c was improved with the BP using fast-acting insulin aspart compared with standard care without increasing CGM-measured hypoglycemia. "
03/01/2010 - "Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study."
12/01/2021 - "The incidence of hypoglycemia was 60.05% and 55.40% (P=0.371), and the incidence of adverse events was 76.60% and 77.70% (P=0.818) in Ruishulin group and NovoRapid group, respectively. "
04/28/2021 - "Rates of overall hypoglycemia (35.56, 37.72 and 38.75 per patient-year of exposure with mealtime fast-acting insulin aspart, post-meal fast-acting insulin aspart and insulin aspart, respectively) and meal-related hypoglycemia were similar between treatment arms. "
10/01/2013 - "Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials."

01/01/2023 - "The present study aimed to compare the pregnancy outcomes, efficacy, and safety of faster aspart with insulin aspart among Indian women with gestational diabetes. "
10/20/2023 - "To analyze the effects of dietary intervention combined with insulin aspart on the serum levels of nesfatin-1, C1q/TNF related protein-12 (CTRP12), and pregnancy outcomes in pregnant women with gestational diabetes mellitus (GDM). "
10/20/2023 - "Effects of dietary intervention combined with insulin aspart on serum nesfatin-1 and CTRP12 levels and pregnancy outcomes in pregnant women with gestational diabetes mellitus."
01/01/2023 - "This retrospective study evaluated the medical records of 60 pregnant women diagnosed with gestational diabetes and managed with faster aspart or insulin aspart at a tertiary care center, between March 2019 and September 2020. "
01/01/2023 - "To compare and evaluate the efficacy and safety of faster aspart and insulin aspart in the management of gestational diabetes. "

07/29/2020 - "Among the three formulations, insulin aspart-loaded BaSO4 and BaCO3 particles dramatically reduced the existing hyperglycemia. "
02/01/2019 - "We used insulin aspart 3u when we found hyperglycemia three times at 9 PM and it was effective. "
01/01/2018 - "Unexplained hyperglycemia and premature infusion set changes were more common with FIASP than with insulin aspart. "
05/01/2011 - "We examined the impact of an aspart insulin protocol for treatment of hyperglycemia in the emergency department (ED) coupled with rapid initiation of a detemir-aspart insulin protocol for patients admitted to the hospital. "
08/01/2022 - "Introduction Faster insulin aspart (fASP) is the new formulation of insulin aspart (ASP) with a left-shifted pharmacokinetic profile, allowing better control of early postprandial hyperglycemia and a reduction in the risk of late post-meal hypoglycemia. "